Ir directamente a la navegación principal Ir directamente a la búsqueda Ir directamente al contenido principal

Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users

Producción científica: Articlerevisión exhaustiva

7 Citas (Scopus)

Resumen

Herpes simplex virus type 2 (HSV-2) is the most common cause of genital ulcer disease and, along with substance abuse, an important HIV risk factor. Therefore, the purpose of this study was to examine HSV-2 seroprevalence in a sample of drug users in rural Appalachia. Rural Appalachian individuals age 18 or older reporting non-medical use of prescription opioids, heroin, crack/cocaine, or methamphetamine in the past 6 months (n=499) were included. Behavioral, demographic, and sexual network data were collected using interviewer-administered questionnaires. Participants' serum was tested for HSV-2 antibodies using the Biokit rapid test (Lexington, MA). The estimated population seroprevalence of HSV-2 was 14.4% (95%CI: 9.6-19.4%). Only 8.8% were aware of being HSV-2+, and unprotected sex was reported in 80% of serodiscordant sexual relationships. In a multivariate model, female gender, age, older age at first oral sex, and frequency of unprotected sex in the sexual network were independently associated with HSV-2 seropositivity. Despite lower seroprevalence than that reported in similar studies of substance abusers, targeted interventions to reduce sexual risk behavior are warranted in this underserved population. Network-informed approaches with particular focus on women, older individuals, and those engaging in frequent unprotected sex are recommended.

Idioma originalEnglish
Páginas (desde-hasta)512-520
Número de páginas9
PublicaciónJournal of Medical Virology
Volumen88
N.º3
DOI
EstadoPublished - mar 1 2016

Nota bibliográfica

Publisher Copyright:
© 2016 Wiley Periodicals, Inc.

Financiación

Grant sponsor: National Institute on Drug Abuse; Grant number: R01DA024598; Grant sponsor: National Center for Research Resources; Grant sponsor: National Center for Advancing Translational Sciences; Grant sponsor: National Institutes of Health (NIH); Grant number: TL1RR033172; Grant sponsor: National Institute on Drug Abuse; Grant number: T32DA035200

FinanciadoresNúmero del financiador
National Institutes of Health (NIH)
National Institute on Drug AbuseR01DA033862, R01DA024598, T32DA035200
National Center for Research ResourcesTL1RR033172
National Center for Advancing Translational Sciences (NCATS)

    ODS de las Naciones Unidas

    Este resultado contribuye a los siguientes Objetivos de Desarrollo Sostenible

    1. Good health and well being
      Good health and well being

    ASJC Scopus subject areas

    • Virology
    • Infectious Diseases

    Huella

    Profundice en los temas de investigación de 'Correlates to seroprevalent herpes simplex virus type 2 among rural Appalachian drug users'. En conjunto forman una huella única.

    Citar esto